Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Cancer
        Considerations for engineering a successful knockout cell line generation.
            January 17, 2025 -
            1 min read
          
          
         
      Cancer
        Homology-directed repair with a plasmid donor: considerations for successful HDR experimental design.
            January 15, 2025 -
            4 min read
          
          
         
       
      Cancer
        Homology-directed repair with a DNA donor oligo: considerations for successful HDR experimental design.
            January 14, 2025 -
            5 min read
          
          
         
      Agricultural Genomics
        Quality assessment of ngs imputation results in agrigenomics.
            January 6, 2025 -
            6 min read
          
          
         
      Agricultural Genomics
        The logic behind imputation analysis in next-generation sequencing for agrigenomics.
            January 6, 2025 -
            5 min read
          
          
         
       
      NGS
        SPRI technology: principles, bead composition, and bead-to-sample ratio impact.
            December 4, 2024 -
            2 min read
          
          
         
      Cancer
        Tips on establishing a reliable cell free DNA (cfDNA) workflow from plasma samples.
            November 26, 2024 -
            6 min read
          
          
         
      NGS
        The Evolution of agrigenomics: From microarrays to next-generation sequencing.
            November 21, 2024 -
            4 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  